Salem Investment Counselors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
EAM
JMFC
ETC
BSWM
FIA
PFSRSONJ
SS
CAL
Salem Investment Counselors's DNA Position: Q2 2026 in Review
Salem Investment Counselors reduced its Ginkgo Bioworks (DNA) stake by 24% in Q2 2026, selling an estimated $1.59K and leaving 591 shares worth $5.86K. The position accounts for ﹤0.01% of the portfolio, ranked #991.
Salem Investment Counselors first reported a position in DNA in Q2 2022 and has held it in 16 quarters since. The position peaked at $5.52M in Q1 2024. 36 funds tracked by Wall St. Rank hold DNA as of Q2 2026.
- Salem Investment Counselors held 591 shares of Ginkgo Bioworks worth $5.86K as of Q2 2026.
- Salem Investment Counselors sold 190 Ginkgo Bioworks shares in Q2 2026, an estimated $1.59K.
- Ginkgo Bioworks made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #991 holding.
- Salem Investment Counselors first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 16 quarters since.
- Salem Investment Counselors's Ginkgo Bioworks position peaked at $5.52M in Q1 2024.
- 36 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.
Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.